Steminent Biotherapeutics Inc. (TPEX:7729)

Market Cap	3.37B
Revenue	n/a
Net Income	n/a
Shares Out	56.11M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,211,048
Average Volume	843,772
Open	58.90
Previous Close	57.90
Day's Range	57.90 - 63.00
52-Week Range	15.25 - 63.00
Beta	n/a
RSI	87.50
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics Inc., operates as a biopharmaceutical company. Its product pipeline includes Stemchymal for treatment for polyglutamine spinocerebellar ataxia, huntington's disease, osteoarthritis, acute syndromes, such as respiratory distress syndrome, liver failure, ischemic stoke. The company was founded in 2009 and is based in Taipei, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729